ANAB CIK: 1370053

AnaptysBio, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
–
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−56.8
FY22:
−115
FY23:
−164
FY24:
66.2
FY25:
227
(positive)
Change from FY21 to FY22
millions USD
FY21:
−54.3
FY22:
−105
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−57.8
FY22:
−129
FY23:
−164
FY24:
31.1
FY25:
162
(positive)
Change from FY21 to FY25
millions USD
FY21:
−57.8
FY22:
−129
FY23:
−164
FY24:
−145
FY25:
−13.2

All amounts in millions USD Data sources:SEC EDGARTwelve Data